s6y

HCW Biologics Inc.

Ticker
HCWB
CIK
1828673
Industry
Pharmaceutical Preparations

Financials 26

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q/A Quarterly Report for period ending Mar 31, 2026
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2025
  9. 10-Q Quarterly Report for period ending Mar 31, 2025
  10. 10-K Annual Report for period ending Dec 31, 2024

All 26 financials filings

News 100

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 100 news filings

Ownership 111

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 111 ownership filings

Prospectus 33

  1. S-1 General form of registration statement for all companies including face-amount certificate companies
  2. S-1/A General form of registration statement for all companies including face-amount certificate companies
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. S-1/A General form of registration statement for all companies including face-amount certificate companies
  5. S-1 General form of registration statement for all companies including face-amount certificate companies
  6. S-1/A General form of registration statement for all companies including face-amount certificate companies
  7. S-1 General form of registration statement for all companies including face-amount certificate companies
  8. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  9. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  10. S-1/A General form of registration statement for all companies including face-amount certificate companies

All 33 prospectus filings

Proxies 18

  1. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  2. DEF 14A Definitive proxy statements
  3. PRER14A Preliminary revised proxy soliciting materials
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 18 proxies filings

Other 59

  1. SCHEDULE 13G
  2. EFFECT Notice of Effectiveness
  3. D Exempt (Private) Offering
  4. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  5. UPLOAD Letter (PDF)
  6. EFFECT Notice of Effectiveness
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. UPLOAD Letter (PDF)
  9. D Exempt (Private) Offering
  10. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing

All 59 other filings